[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence

R Nevola, R Ruocco, L Criscuolo, A Villani… - World journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

[HTML][HTML] Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma

C Akateh, SM Black, L Conteh, ED Miller… - World journal of …, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and a
major cause of cancer-related mortality for which liver resection is an important curative …

Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi …

LQ Yao, ZL Chen, ZH Feng, YK Diao, C Li… - Annals of surgical …, 2022 - Springer
Background A potentially curative hepatic resection is the optimal treatment for
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …

Early and late recurrence of hepatitis B virus‐associated hepatocellular carcinoma

MD Wang, C Li, L Liang, H Xing, LY Sun, B Quan… - The …, 2020 - academic.oup.com
Background Survival after liver resection of hepatocellular carcinoma (HCC) remains poor
because of a high incidence of recurrence. We sought to investigate risk factors, patterns …

Association of preoperative antiviral treatment with incidences of microvascular invasion and early tumor recurrence in hepatitis b virus–related hepatocellular …

Z Li, Z Lei, Y Xia, J Li, K Wang, H Zhang, X Wan… - JAMA …, 2018 - jamanetwork.com
Importance A reduced incidence of microvascular invasion (MVI) in hepatitis B virus (HBV)–
related hepatocellular carcinoma (HCC) may be associated with a decreased risk of early …

Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: a meta-analysis

X Xu, Y Tan, Y Qian, W Xue, Y Wang, J Du, L Jin… - Medicine, 2019 - journals.lww.com
Background: In patients with hepatocellular carcinoma (HCC), the clinicopathologic and
prognostic roles of tumor-infiltrating CD8+ T cells for survival are still controversial. A meta …

[HTML][HTML] Advances in postoperative adjuvant therapy for primary liver cancer

ZM Zeng, N Mo, J Zeng, FC Ma, YF Jiang… - World journal of …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a highly heterogeneous, invasive, and conventional
chemotherapy-insensitive tumor with unique biological characteristics. The main methods …

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study

WT Yan, C Li, LQ Yao, HB Qiu… - Hepatobiliary …, 2021 - pmc.ncbi.nlm.nih.gov
Background Recurrence is common among patients undergoing hepatic resection for
hepatocellular carcinoma (HCC), which greatly limits long-term survival. We aimed to …

[HTML][HTML] Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg

IC Lee, HJ Lei, GY Chau, YC Yeh, CJ Wu… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The recurrence rate remains high even under nucleos (t) ide analogues (NUCs) therapy in
patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after resection …

Robotic versus laparoscopic left lateral sectionectomy of liver

JK Kim, JS Park, DH Han, GH Choi, KS Kim, JS Choi… - Surgical …, 2016 - Springer
Background A few studies have reported only short-term outcomes of various robotic and
laparoscopic liver resection types; however, published data in left lateral sectionectomy …